stock offering Oncocyte Prices $35M Stock, Warrant Public Offering Proceeds from the offering, expected to close around April 19, will go toward the development and commercialization of the firm's various tests. Twist Bioscience to Raise $250M in Upsized Public Stock Offering JP Morgan, Goldman Sachs, Cowen, and William Blair are acting as joint book-running managers for Twist's first offering of common stock in more than a year. Personalis Signs Deal With BTIG for $100M At-Market Stock Offering The company said any proceeds raised will support working capital and general corporate purposes, including research and development programs. Proteomics Goes Public in 2021 Premium Seven proteomics firms, ranging from tools companies to diagnostics outfits, listed on public markets in 2021 in a sign of growing interest in the space. 908 Devices Prices $100M Public Offering The company priced a public offering of 3,150,000 shares of its common stock at $32.00 per share that is expected to gross approximately $100.8 million. Oct 14, 2021 OpGen Enters $15M Registered Direct Offering Agreement Jul 23, 2021 Cytek Biosciences Prices $200M Initial Public Offering Jul 21, 2021 Natera Prices, Upsizes Public Stock Offering Jul 20, 2021 Pacific Biosciences to Acquire Omniome for up to $800M, Expand Invitae Collaboration Jul 13, 2021 Olink Reports Preliminary Q2 Revenues Between $17.3M and $17.7M, Inks Decode Deal Jun 25, 2021 Angle to Raise £20M Through Stock Placement Jun 14, 2021 Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock May 27, 2021 Singular Genomics Systems Raises $258M in Upsized IPO Mar 29, 2021 SomaLogic to Go Public Through Merger With Special Purpose Acquisition Company Mar 25, 2021 Olink Prices $264M Initial Public Offering Mar 10, 2021 Investor Interest in Proteomics Rising on New, Improving Technologies Premium Feb 11, 2021 Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering Feb 9, 2021 OpGen Enters $25M Direct Offering Agreement Feb 5, 2021 Oncocyte to Raise $35M in Public Stock Offering Feb 5, 2021 Veracyte Prices $550M Public Offering of Common Stock Feb 4, 2021 Quanterix Prices $250M Public Stock Offering Jan 28, 2021 Seer Prices $110.5M Follow-on Stock Offering Jan 27, 2021 Personalis Prices $150M Public Stock Offering Jan 26, 2021 Seer Plans Offering of 3.5M Shares of Common Stock Jan 22, 2021 Predictive Oncology Announces $4.1M Direct Offering Load More Breaking News Single-Nucleus Chromatin Accessibility Profiling in Coronary Artery Disease Points to Mechanisms ALL Genomes Marked by High DNA Methylation Levels Cepheid Gets CE Mark for Updated Rapid COVID MDx Test Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE CellCarta Acquires Rights to Targeted Protein Assays from Fred Hutch Spinout Precision Assays Genetic Analysis, Omnigene Medical Technologies Ink Distribution, Tech Transfer Deal The Scan Monkeypox Case Found in US The New York Times says that a case of monkeypox has now been reported in the US. Effects on Fetal Screening Wired writes that changes to US abortion laws could affect screening for fatal congenital conditions. 'Pharma Bro' Out of Prison The Wall Street Journal reports that Martin Shkreli has been released from prison to a halfway house. Nature Papers Present Cultivate Oat Genome, Benchmarking of Spatial and Single-Cell Transcriptomic Integration Methods In Nature this week: reference genome of the cultivated oat, and more.